Craniomaxillofacial Surgery in China: What Lies Ahead?

Qingfeng Li,Dong Yu

DOI: https://doi.org/10.1097/prs.0b013e31824199da

2012-01-01

Plastic & Reconstructive Surgery

Abstract:Sir:FigureTracing back history, in 1962, Paul Tessier established a milestone by performing the world's first surgical correction of orbital hypertelorism, thereby marking the birth of a new operation in craniomaxillofacial surgery. In 1977, Professor Ti-Sheng Chang of the Shanghai Ninth People's Hospital performed the very first operations for hypertelorism, thereby proclaiming the establishment of craniofacial surgery in China. This field continued to consolidate and expand rapidly. In contrast to the congenital nature of craniofacial deformities in Western countries, the focus of attention in Asian countries has been directed at facial contouring. Prominent mandibular angles have become synonymous with Asian craniofacial surgery. Despite the fact that the field of craniomaxillofacial surgery originated from the need to correct congenital craniofacial deformities, in China, the incidence of such anomalies as scaphocephaly is much less than in Western countries. To illustrate this difference, in Shanghai Ninth People's Hospital, China's largest and most authoritative center for craniofacial surgery, there is an average of 40 anomaly cases annually (<10 percent of total hospital admissions). Is the development of craniofacial surgery in China limited to the treatment of prominent mandibular angle? There is little potential for further improvement in the field of surgery for the mandibular angle, despite its being one of the pillar techniques. It is my belief that the area for potential improvement lies in the advancement of the existing surgical devices. Some surgeons shift toward orthognathic surgery. This brings us to the question of a well-established class I academic discipline such as stomatology. What is the competitive edge that can be offered by the new field of craniomaxillofacial surgery? Some experts have also proposed embracing soft-tissue reconstructive surgery into craniomaxillofacial surgery. However, this change to advocating for the use of soft tissue as a reconstructive material is inherently contradictory to the traditional characteristic feature of craniofacial surgery—use of bone for reconstruction. Eliminating this unique feature poses a direct question to the existence of craniomaxillofacial surgery. Craniomaxillofacial surgery seems to have made little progress since being founded by Tessier. It is my belief that the field of craniofacial surgery is still at a primitive stage and lacks a clear direction for future development. Whenever I witness disappointing results and poor patient satisfaction, I cannot help but to suspect that unperfected surgical technique is the underlying culprit. Perhaps most doubtful of all is craniofacial bone grafting, as clinically we have observed poor graft absorption rates, in comparison with other parts of the body. Returning to the question of where craniomaxillofacial science is heading: Tessier formulated the core principles and theories by relying mostly on his clinical explorations as opposed to formal scientific research. It is the authors' opinion that through finding the answers to the questions raised by his theories and conducting extensive scientific research, one will pave the way for the next breakthrough in this field. Qingfeng Li, M.D. Dong Yu, M.D. Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China